Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases

BACKGROUND: Sugammadex is a novel, rapidly-acting pharmacologic agent to reverse steroidal neuromuscular blocking agents with demonstrated advantages over acetylcholinesterase inhibitors. However, anecdotal reports have noted rare instances of bradycardia and even cardiac arrest. The current study e...

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, Jordan, Hubbard, Richard, Shafy, Shabana Z., Hakim, Mohammed, Kim, Stephani S., Tumin, Dmitry, Tobias, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430884/
https://www.ncbi.nlm.nih.gov/pubmed/32849961
http://dx.doi.org/10.14740/cr1045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430884/
https://www.ncbi.nlm.nih.gov/pubmed/32849961
http://dx.doi.org/10.14740/cr1045

Ejemplares similares